Aytu Biopharma (AYTU) Change in Account Payables (2014 - 2026)
Aytu Biopharma (AYTU) posted quarterly Change in Account Payables of -$1.0 million for Q1 2026, down 362.56% year-over-year from $398000.0 in Q1 2025, and up 3.51% quarter-over-quarter from -$1.1 million in Q4 2025.
Aytu Biopharma (AYTU) Change in Account Payables (2014 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Change in Account Payables for 10 consecutive years, with -$1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 362.56% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$1.8 million (down 198.17% YoY), while the FY2025 annual figure was $287000.0, up 113.82% from the prior year.
- Change in Account Payables climbed to -$1.0 million in Q1 2026 per AYTU's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.6 million in Q1 2023 and bottomed at -$4.8 million in Q1 2022.
- Historically, Change in Account Payables has averaged -$245058.8 across 5 years, with a median of $134000.0 in 2024.
- Annual changes were most pronounced in 2024 — Change in Account Payables soared 232.24% — and 2025, when it sank 1174.63%.
- Aytu Biopharma's Change in Account Payables stood at -$4.4 million in 2022, then advanced by 9.42% to -$4.0 million in 2023, then jumped by 54.74% to -$1.8 million in 2024, then soared by 40.3% to -$1.1 million in 2025, then increased by 3.51% to -$1.0 million in 2026.
- Business Quant data shows AYTU's Change in Account Payables at -$1.0 million in Q1 2026, -$1.1 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | -1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.05 Mn |
| Mar 31, 2026 | -1.05 Mn |
| Dec 31, 2025 | -1.08 Mn |
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | -1.44 Mn |
| Mar 31, 2025 | 398,000.00 |
| Mar 31, 2025 | 398,000.00 |
| Dec 31, 2024 | -1.81 Mn |
| Dec 31, 2024 | -1.81 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 134,000.00 |
| Jun 30, 2024 | 134,000.00 |
| Mar 31, 2024 | 852,000.00 |
| Mar 31, 2024 | 852,000.00 |
| Dec 31, 2023 | -4.01 Mn |
| Dec 31, 2023 | -4.01 Mn |